Trueblood Wealth Management’s Capital Group Dividend Value ETF CGDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Sell
39,614
-202
-0.5% -$9.51K 0.68% 39
2026
Q1
$1.69M Buy
39,816
+1,688
+4% +$75K 0.66% 43
2025
Q4
$1.66M Buy
38,128
+3,586
+10% +$154K 0.65% 43
2025
Q3
$1.45M Buy
34,542
+1,852
+6% +$76.1K 0.57% 57
2025
Q2
$1.29M Buy
32,690
+3,065
+10% +$111K 0.54% 58
2025
Q1
$1.06M Buy
29,625
+10,055
+51% +$365K 0.49% 68
2024
Q4
$690K Buy
19,570
+3,169
+19% +$115K 0.34% 100
2024
Q3
$598K Buy
16,401
+4,918
+43% +$171K 0.3% 112
2024
Q2
$379K Buy
11,483
+4,272
+59% +$139K 0.21% 138
2024
Q1
$234K Buy
+7,211
New +$222K 0.13% 194

Other funds holding CGDV

Trueblood Wealth Management's CGDV Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Capital Group Dividend Value ETF (CGDV) stake by 0.51% in Q2 2026, selling an estimated $9.51K and leaving 39,614 shares worth $1.95M. The position accounts for 0.68% of the portfolio, ranked #39.

Trueblood Wealth Management first reported a position in CGDV in Q1 2024 and has held it in 10 quarters since. 777 funds tracked by Wall St. Rank hold CGDV as of Q2 2026.

  • Trueblood Wealth Management held 39,614 shares of Capital Group Dividend Value ETF worth $1.95M as of Q2 2026.
  • Trueblood Wealth Management sold 202 Capital Group Dividend Value ETF shares in Q2 2026, an estimated $9.51K.
  • Capital Group Dividend Value ETF made up 0.68% of Trueblood Wealth Management's portfolio in Q2 2026, its #39 holding.
  • Trueblood Wealth Management first reported a position in Capital Group Dividend Value ETF in Q1 2024 and has held it in 10 quarters since.
  • 777 funds tracked by Wall St. Rank held Capital Group Dividend Value ETF as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.